Einstein Research Leads to New Drug for Hard-to-Treat Lymphomas

April 14, 2017—(BRONX, NY)—Japan has become the first country to approve a lymphoma drug developed through research at Albert Einstein College of Medicine. This also marks the first time that an Einstein-licensed drug has been approved for patient use.
Source: Einstein News - Category: Universities & Medical Training Source Type: news